Mader Timothy J, Nathanson Brian H, Soares William E, Coute Ryan A, McNally Bryan F
Department of Emergency Medicine, Baystate Medical Center, Tufts University School of Medicine , Springfield, Massachusetts.
OptiStatim, LLC , Longmeadow, Massachusetts.
Ther Hypothermia Temp Manag. 2014 Mar 1;4(1):21-31. doi: 10.1089/ther.2013.0018.
This study was done to determine the effectiveness of therapeutic hypothermia (TH) after out-of-hospital cardiac arrest (OHCA) among a large cohort of adults in the Cardiac Arrest Registry to Enhance Survival (CARES), with an emphasis on subgroups with a nonshockable first documented rhythm. This was an IRB approved retrospective cohort study. All adult index events at participating sites from November 2010 to December 2013 were study eligible. All patient data elements were provided. Summary statistics were calculated for all patients with and without TH. For multivariate adjustment, a multilevel (i.e., hierarchical), mixed-effects logistic regression (MLR) model was used with hospitals treated as random effects. Propensity score matching (PSM) on both shockable and nonshockable patients was done as a sensitivity analysis. After predefined exclusions, our final sample size was 6369 records for analysis: shockable=2992 (47.0%); asystole=1657 (26.0%); pulseless electrical activity=1249 (19.6%); other unspecified nonshockable=471 (7.4%). Unadjusted differences in neurological status at hospital discharge with and without TH were similar (=0.295). After multivariate adjustment, TH had either no association with good neurological status at hospital discharge or that TH was actually associated with worse neurological outcome, particularly in patients with a nonshockable first documented rhythm (i.e., for NS patients, MLR odds ratio for TH=1.444; 95% CI [1.039, 2.006] =0.029, and OR=1.017, =0.927 via PSM). Highlighting our limitations, we conclude that when TH is indiscriminately provided to a large population of OHCA survivors with a nonshockable first documented rhythm, evidence for its effectiveness is diminished. We suggest more uniform and rigid guidelines for application.
本研究旨在确定院外心脏骤停(OHCA)后治疗性低温(TH)在心脏骤停登记以提高生存率(CARES)大型成年队列中的有效性,重点关注首次记录节律不可电击复律的亚组。这是一项经机构审查委员会(IRB)批准的回顾性队列研究。2010年11月至2013年12月参与研究地点的所有成年索引事件均符合研究条件。提供了所有患者的数据元素。计算了接受和未接受TH治疗的所有患者的汇总统计数据。对于多变量调整,使用了以医院为随机效应的多级(即分层)混合效应逻辑回归(MLR)模型。对可电击复律和不可电击复律患者均进行倾向评分匹配(PSM)作为敏感性分析。经过预定义的排除后,我们最终的分析样本量为6369条记录:可电击复律=2992例(47.0%);心搏停止=1657例(26.0%);无脉电活动=1249例(19.6%);其他未指定的不可电击复律=471例(7.4%)。接受和未接受TH治疗的患者出院时神经功能状态的未调整差异相似(=0.295)。多变量调整后,TH与出院时良好的神经功能状态要么无关联,要么实际上与更差的神经结局相关,特别是在首次记录节律不可电击复律的患者中(即对于不可电击复律患者,TH的MLR优势比=1.444;95%可信区间[1.039, 2.006]=0.029,通过PSM得出的OR=1.017,=0.927)。突出我们的局限性,我们得出结论,当TH被不加区分地应用于大量首次记录节律不可电击复律的OHCA幸存者时,其有效性的证据会减少。我们建议采用更统一和严格的应用指南。